VYM
DividendVanguard High Dividend Yield Index Fund ETF Shares
Vanguard · Tracks FTSE High Dividend Yield Index · Inception Nov 10, 2006
Composite score
Based on a 0.040% expense ratio.
Based on $96.17B in net assets.
Top-10 holdings represent 25.6% of net assets.
Dividend base · ETF wrapper · 2.27% TTM yield.
The composite is a weighted average of the four core sub-scores above (cost, tax efficiency, liquidity, concentration). Missing sub-scores fall back to the per-category median when the category has at least 50% data coverage, so funds without (e.g.) parsed N-PORT holdings aren't accidentally boosted by renormalization. Tracking quality is shown where computable but isn't currently part of the composite weighting. See methodology for formulas, the tracking-quality partial-coverage rationale, and the dimensions we deliberately don't score (methodology v0.5.1).
Use VYM in our tools
Tool · Cost
Compare VYM's fee against another fund
Compounds the 0.040% expense ratio against a peer over decades.
Tool · Overlap
Compare VYM's holdings with peers
Pairwise holdings heatmap, pre-loaded with similar Dividend funds.
Tool · TLH
Find a tax-loss harvesting partner for VYM
Ranks every catalog fund by holdings overlap, flags wash-sale risk.
Tool · Placement
Where should this fund live across your accounts?
Asset-location optimizer — places each fund in taxable / tax-deferred / Roth.
Top holdings
| # | Holding | Weight |
|---|---|---|
| 1 | Broadcom Inc | 8.03% |
| 2 | JPMorgan Chase & Co | 3.34% |
| 3 | Exxon Mobil Corp | 2.72% |
| 4 | Johnson & Johnson | 2.30% |
| 5 | Caterpillar Inc | 1.72% |
| 6 | AbbVie Inc | 1.56% |
| 7 | Cisco Systems Inc | 1.52% |
| 8 | Chevron Corp | 1.51% |
| 9 | Bank of America Corp | 1.44% |
| 10 | Procter & Gamble Co/The | 1.44% |
Compare VYM with another fund
Or skim the closest-overlap funds below.
Similar ETFs by holdings overlap
Open VYM at a brokerage
Affiliate links — opening an account through these earns PlainIndex a one-time referral. Scoring is computed before any affiliate consideration; see our methodology and funding disclosure.